+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Endocrine And Metabolic Disorders Drugs Market Research Reports

Insulin Manufacturing in the US - Industry Market Research Report - Product Thumbnail Image

Insulin Manufacturing in the US - Industry Market Research Report

  • Report
  • November 2023
  • 70 Pages
  • United States
From
Global Tri Calcium Phosphate Market Analysis: Plant Capacity, Production, Operating Efficiency, Demand & Supply, End-User Industries, Sales Channel, Regional Demand, Foreign Trade, Company Share, 2015-2032 - Product Thumbnail Image

Global Tri Calcium Phosphate Market Analysis: Plant Capacity, Production, Operating Efficiency, Demand & Supply, End-User Industries, Sales Channel, Regional Demand, Foreign Trade, Company Share, 2015-2032

  • Report
  • October 2023
  • Global
From
Glycogen Storage Disease (GSD) Type 1a Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access - Product Thumbnail Image

Glycogen Storage Disease (GSD) Type 1a Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access

  • Report
  • August 2023
  • 28 Pages
  • Global
Calcium Lactate Market, By Application and Geography Drivers, Opportunities, Trends, and Forecasts Up to 2028 - Product Thumbnail Image

Calcium Lactate Market, By Application and Geography Drivers, Opportunities, Trends, and Forecasts Up to 2028

  • Report
  • August 2023
  • 115 Pages
  • Global
From
Thyroid Gland Disorder Treatment Market by Disease Type, Drug Type, Route of Administration, and Distribution/Sales Channel: Global and Forecast up to 2027 - Product Thumbnail Image

Thyroid Gland Disorder Treatment Market by Disease Type, Drug Type, Route of Administration, and Distribution/Sales Channel: Global and Forecast up to 2027

  • Report
  • July 2023
  • 223 Pages
  • Global
From
Iodine Deficiency Drug Market by Distribution Channel, Dosage Form, and Geography: Forecast up to 2027 - Product Thumbnail Image

Iodine Deficiency Drug Market by Distribution Channel, Dosage Form, and Geography: Forecast up to 2027

  • Report
  • July 2023
  • 173 Pages
  • Global
From
Graves' Disease Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access - Product Thumbnail Image

Graves' Disease Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access

  • Report
  • June 2023
  • 22 Pages
  • Global
Delayed Onset Type 1 Diabetes Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access - Product Thumbnail Image

Delayed Onset Type 1 Diabetes Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access

  • Report
  • March 2023
  • 26 Pages
  • Global
United States Insulin Syringes Market and Forecast 2021-2027 - Product Thumbnail Image

United States Insulin Syringes Market and Forecast 2021-2027

  • Report
  • October 2021
  • 70 Pages
  • United States
From
United States Insulin Injection Pen Market - Growth, Trends and Forecasts (2021 - 2027) - Product Thumbnail Image

United States Insulin Injection Pen Market - Growth, Trends and Forecasts (2021 - 2027)

  • Report
  • April 2021
  • 85 Pages
  • United States
From
Merck Steps Out Of Insulin Glargine Market, But Says It Remains Committed To Biosimilars - Product Thumbnail Image

Merck Steps Out Of Insulin Glargine Market, But Says It Remains Committed To Biosimilars

  • Newsletter
  • November 2024
  • 3 Pages
  • Global
From
UAE Insulin Delivery Devices Market, By Region, By Competition Forecast & Opportunities, 2018-2028F - Product Thumbnail Image

UAE Insulin Delivery Devices Market, By Region, By Competition Forecast & Opportunities, 2018-2028F

  • Report
  • November 2023
  • 83 Pages
  • United Arab Emirates United Arab Emirates
From
Surepost - API Insight, 2022 - Product Thumbnail Image

Surepost - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Novothyrox - API Insight, 2022 - Product Thumbnail Image

Novothyrox - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Onglyza - API Insight, 2022 - Product Thumbnail Image

Onglyza - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Proscar - API Insight, 2022 - Product Thumbnail Image

Proscar - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Propecia - API Insight, 2022 - Product Thumbnail Image

Propecia - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Nesina - API Insight, 2022 - Product Thumbnail Image

Nesina - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Zometa Concentrate - API Insight, 2022 - Product Thumbnail Image

Zometa Concentrate - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Optruma - API Insight, 2022 - Product Thumbnail Image

Optruma - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Loading Indicator

The Endocrine and Metabolic Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat endocrine and metabolic disorders. Endocrine disorders are conditions that affect the body's hormones, while metabolic disorders are conditions that affect the body's ability to process and use energy. Endocrine and metabolic disorders can include diabetes, thyroid disorders, obesity, and adrenal disorders. Endocrine and Metabolic Disorders Drugs are typically developed by pharmaceutical companies and are prescribed by physicians. These drugs can be used to treat a variety of endocrine and metabolic disorders, including diabetes, thyroid disorders, obesity, and adrenal disorders. Common drugs used to treat these conditions include insulin, metformin, and glucagon-like peptide-1 (GLP-1) agonists. Some of the major companies in the Endocrine and Metabolic Disorders Drugs market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. These companies are involved in the development, production, and marketing of drugs used to treat endocrine and metabolic disorders. Show Less Read more